Performance of the Self‐Controlled Case Series With Active Comparators for Drug Safety Signal Detection Using the French Administrative Healthcare Database ( <scp>SNDS</scp> )

The SNDS is a useful data source for signal detection, particularly for outcomes captured in hospitals. Using a carefully designed reference set of drug-outcome pairs well suited to the study design, the SCCS achieved satisfactory performance for signal detection in this database. In this study, the use of active comparators improved overall performance at the expense of greatly reduced sensitivity.

Authors

Institutions

Publication Details

Journal
Pharmacoepidemiology and Drug Safety
Published
2025-11-01
DOI
https://doi.org/10.1002/pds.70224
Primary Topic
Pharmacovigilance and Adverse Drug Reactions
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Performance of the Self‐Controlled Case Series With Active Comparators for Drug Safety Signal Detection Using the French Administrative Healthcare Database ( SNDS )

Andrew Bate, Angel Y. S. Wong, François Haguinet, Ian Douglas et al.
Pharmacoepidemiology and Drug Safety
Pharmacovigilance and Adverse Drug Reactions
article

Performance of the Self‐Controlled Case Series With Active Comparators for Drug Safety Signal Detection Using the French Administrative Healthcare Database ( SNDS )

Andrew Bate, Angel Y. S. Wong, François Haguinet, Ian Douglas, Astrid Coste
article en

Abstract

The SNDS is a useful data source for signal detection, particularly for outcomes captured in hospitals. Using a carefully designed reference set of drug-outcome pairs well suited to the study design, the SCCS achieved satisfactory performance for signal detection in this database. In this study, the use of active comparators improved overall performance at the expense of greatly reduced sensitivity.

Pharmacoepidemiology and Drug SafetyVol. 34(11)
London School of Hygiene & Tropical Medicine (GB), GlaxoSmithKline (Belgium) (BE), Center for Non-Communicable Diseases (PK)
GlaxoSmithKline
Openalex Percentile: Top 66%
Pharmacovigilance and Adverse Drug Reactions
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.